Cor H. van der Leest

579 citations

16 papers · 289 indexed · h-index 7

Co-authors: Joachim G.J.V. Aerts Stijn L.W. Koolen Ron H.J. Mathijssen Astrid A.M. van der Veldt Esther Oomen‐de Hoop Reno Debets Edwin A. Basak Sander Bins
Topics: Cancer Immunotherapy and Biomarkers (10 papers)Lung Cancer Treatments and Mutations (10 papers)Pancreatic and Hepatic Oncology Research (3 papers)
Cited by: Oncology Immunology Pulmonary and Respiratory Medicine
Journals: Clinical Cancer Research British Journal of Cancer Annals of Oncology
Partner nations: Netherlands Switzerland Chile

In The Last Decade

Cor H. van der Leest

13 papers receiving 288 citations

Peers

Countries citing papers authored by Cor H. van der Leest

Since Specialization

Citations

This map shows the geographic impact of Cor H. van der Leest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cor H. van der Leest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cor H. van der Leest more than expected).

Fields of papers citing papers by Cor H. van der Leest

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cor H. van der Leest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cor H. van der Leest. The network helps show where Cor H. van der Leest may publish in the future.

Co-authorship network of co-authors of Cor H. van der Leest

This figure shows the co-authorship network connecting the top 25 collaborators of Cor H. van der Leest. A scholar is included among the top collaborators of Cor H. van der Leest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cor H. van der Leest. Cor H. van der Leest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	The Toxicity Profile of Pemetrexed in Non-Small Cell Lung Cancer Patients With Moderate Renal Impairment: A Retrospective Cohort Study 2025 ·Clinical Lung Cancer ·(unknown),Rob ter Heine,(unknown),(unknown),(unknown),Bas Peters,Nienke A. G. Lankheet,(unknown),(unknown),Eric J. F. Franssen,(unknown),Cor H. van der Leest,(unknown),(unknown),(unknown),John W.G. van Putten,Ben E.E.M. van den Borne,Michel M. van den Heuvel,Maarten J. Deenen	0
2	The effectiveness of pembrolizumab maintenance with or without pemetrexed after induction treatment for advanced non-squamous Non–Small-Cell Lung cancer 2025 ·Lung Cancer ·Bas Peters,(unknown),Doranne L. Hilarius,Stefan Böhringer,J. Zwaveling,(unknown),Cor H. van der Leest,(unknown)	0
3	1335P The relationship between nivolumab pharmacokinetics and cancer cachexia biomarkers in patients with metastatic non-small cell lung cancer (NSCLC) 2024 ·Annals of Oncology ·Michael S. Hofman,(unknown),Juliette Degens,(unknown),Daphne W. Dumoulin,Annemie Schols,(unknown),Christianne Groeneveldt,Wouter R. P. H. van de Worp,Lizza Hendriks,Cor H. van der Leest,(unknown),(unknown),Anne‐Marie C. Dingemans,Ramon Langen,(unknown)	1
4	Bronchiolitis after Combination Immunotherapy With Ipilimumab and Nivolumab in a Melanoma Patient 2024 ·Journal of Immunotherapy ·(unknown),(unknown),Hans M. Westgeest,(unknown),Jochem R. van Werven,Cor H. van der Leest	0
5	A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer 2023 ·Targeted Oncology ·Rob ter Heine,Michel M. van den Heuvel,Berber Piet,Maarten J. Deenen,Anthonie J. van der Wekken,Lizza Hendriks,Sander Croes,Robin M.J.M. van Geel,Frank G. A. Jansman,R.C. Boshuizen,Eric J. F. Franssen,(unknown),Daphne W. Dumoulin,Thijs H. Oude Munnink,Egbert F. Smit,Hieronymus J. Derijks,Cor H. van der Leest,Jeroen J. M. A. Hendrikx,Dirk Jan A. R. Moes,(unknown)	8
6	Clinical Outcomes of Patients With Metastatic NSCLC After Discontinuation of Immunotherapy Because of Immune-Related Adverse Effects 2022 ·JTO Clinical and Research Reports ·Lysanne A. Lievense,Peter Heukels,(unknown),Cor H. van der Leest	6
7	The course of C-peptide levels in patients developing diabetes during anti-PD-1 therapy 2022 ·Biomedicine & Pharmacotherapy ·Edwin A. Basak,Karlijn de Joode,(unknown),(unknown),Marco W.J. Schreurs,Sjoerd A.A. van den Berg,Esther Oomen‐de Hoop,Cor H. van der Leest,Layal Chaker,Richard A. Feelders,Astrid A.M. van der Veldt,Arjen Joosse,Stijn L.W. Koolen,Joachim G.J.V. Aerts,Ron H.J. Mathijssen,Sander Bins	4
8	Influence of esomeprazole on the bioavailability of afatinib: A pharmacokinetic cross-over study in patients with non-small cell lung cancer 2022 ·Biomedicine & Pharmacotherapy ·G. Veerman,Daan P. Hurkmans,Marthe S. Paats,Esther Oomen‐de Hoop,Cor H. van der Leest,(unknown),Joachim G.J.V. Aerts,(unknown),Anne‐Marie C. Dingemans,Ron H.J. Mathijssen	1
9	Prospective real-world study on the pharmacokinetics of pembrolizumab in patients with solid tumors 2021 ·Journal for ImmunoTherapy of Cancer ·Daan P. Hurkmans,(unknown),Karlijn de Joode,(unknown),Edwin A. Basak,Annemarie Wijkhuijs,Markus Joerger,Reno Debets,Birgit C. P. Koch,Cor H. van der Leest,Marco W.J. Schreurs,Astrid A.M. van der Veldt,Joachim G.J.V. Aerts,Ron H.J. Mathijssen,Stijn L.W. Koolen	15
10	Influence of Cow’s Milk and Esomeprazole on the Absorption of Erlotinib: A Randomized, Crossover Pharmacokinetic Study in Lung Cancer Patients 2020 ·Clinical Pharmacokinetics ·G. Veerman,Koen G. A. M. Hussaarts,(unknown),Esther Oomen‐de Hoop,(unknown),Cor H. van der Leest,(unknown),(unknown),Huub Belderbos,(unknown),Marthe S. Paats,Stijn L.W. Koolen,Anne‐Marie C. Dingemans,Teun van Gelder,Roelof W. F. van Leeuwen,Joachim G.J.V. Aerts,Ron H.J. Mathijssen	11
11	Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer 2020 ·Journal for ImmunoTherapy of Cancer ·Daan P. Hurkmans,Edwin A. Basak,(unknown),Esther Oomen‐de Hoop,Cor H. van der Leest,Samira El Bouazzaoui,Sander Bins,Stijn L.W. Koolen,Stefan Sleijfer,Astrid A.M. van der Veldt,Reno Debets,Ron H. N. van Schaik,Joachim G.J.V. Aerts,Ron H.J. Mathijssen	51
12	A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients 2019 ·Journal for ImmunoTherapy of Cancer ·Daan P. Hurkmans,Edwin A. Basak,(unknown),(unknown),Marco W.J. Schreurs,Annemarie Wijkhuijs,Sander Bins,Esther Oomen‐de Hoop,Reno Debets,Markus Joerger,Arlette E. Odink,Astrid A.M. van der Veldt,Cor H. van der Leest,Joachim G.J.V. Aerts,Ron H.J. Mathijssen,Stijn L.W. Koolen	66
13	Influence of cow’s milk on the absorption and exposure of erlotinib in NSCLC patients 2019 ·Annals of Oncology ·G. Veerman,Koen G. A. M. Hussaarts,(unknown),Esther Oomen‐de Hoop,(unknown),Cor H. van der Leest,(unknown),(unknown),Marthe S. Paats,Teun van Gelder,Stijn L.W. Koolen,Joachim G.J.V. Aerts,(unknown),Ron H.J. Mathijssen	1
14	A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients 2019 ·Annals of Oncology ·Daan P. Hurkmans,Edwin A. Basak,(unknown),(unknown),Marco W.J. Schreurs,Annemarie Wijkhuijs,Sander Bins,Esther Oomen‐de Hoop,Reno Debets,Markus Joerger,Arlette E. Odink,Astrid A.M. van der Veldt,Cor H. van der Leest,Joachim G.J.V. Aerts,Ron H.J. Mathijssen,Stijn L.W. Koolen	2
15	Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients 2018 ·British Journal of Cancer ·Sander Bins,Edwin A. Basak,Samira El Bouazzaoui,Stijn L.W. Koolen,Esther Oomen‐de Hoop,Cor H. van der Leest,Astrid A.M. van der Veldt,Stefan Sleijfer,Reno Debets,Ron H. N. van Schaik,Joachim G.J.V. Aerts,Ron H.J. Mathijssen	52
16	Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human 2017 ·Clinical Cancer Research ·Joachim G.J.V. Aerts,Pauline L. de Goeje,Robin Cornelissen,Margaretha E.H. Kaijen-Lambers,Koen Bezemer,Cor H. van der Leest,Niken M. Mahaweni,André Kunert,Ferry A.L.M. Eskens,Cynthia Waasdorp,Eric Braakman,Bronno van der Holt,Arnold G. Vulto,Rudi W. Hendriks,Joost P. Hegmans,Henk C. Hoogsteden	71

About Cor H. van der Leest

Cor H. van der Leest is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology, having authored 16 papers that have together received 289 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Treatments and Mutations (10 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Oncology (206 citations), Immunology (93 citations) and Pulmonary and Respiratory Medicine (110 citations). Cor H. van der Leest has collaborated with scholars based in Netherlands, Switzerland and Chile. Frequent co-authors include Joachim G.J.V. Aerts, Stijn L.W. Koolen, Ron H.J. Mathijssen, Astrid A.M. van der Veldt, Esther Oomen‐de Hoop, Reno Debets, Edwin A. Basak, Sander Bins, Daan P. Hurkmans and Samira El Bouazzaoui. Their work appears in journals such as Clinical Cancer Research, British Journal of Cancer and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact